Dorothea Buck
Articles 39
-
Effect of HLA-DRB1 alleles and genetic variants on the development of neutralizing antibodies to interferon beta in the BEYOND and BENEFIT trials.
-
Serum heat shock protein 70 levels as a biomarker for inflammatory processes in multiple sclerosis.
-
Low frequency and rare coding variation contributes to multiple sclerosis risk
-
Clinical practice of analysis of anti-drug antibodies against interferon beta and natalizumab in multiple sclerosis patients in Europe: A descriptive study of test results
-
Cortical pathology in multiple sclerosis detected by the T1/T2-weighted ratio from routine magnetic resonance imaging.
-
Interferon-beta specific T cells are associated with the development of neutralizing antibodies in interferon-beta treated multiple sclerosis patients.
-
Fatigue in multiple sclerosis: Associations with clinical, MRI and CSF parameters.
-
The Multiple Sclerosis Genomic Map: Role of peripheral immune cells and resident microglia in susceptibility
-
Occurrence of Anti-Drug Antibodies against Interferon-Beta and Natalizumab in Multiple Sclerosis: A Collaborative Cohort Analysis
-
Novel multiple sclerosis susceptibility loci implicated in epigenetic regulation
-
Retinal inner nuclear layer volume reflects response to immunotherapy in multiple sclerosis.
-
The farnesoid-X-receptor in myeloid cells controls CNS autoimmunity in an IL-10-dependent fashion.
-
Class II HLA interactions modulate genetic risk for multiple sclerosis
-
Successful Replication of GWAS Hits for Multiple Sclerosis in 10,000 Germans Using the Exome Array
-
Prevalence of neuropathic pain in early multiple sclerosis
-
Mapping CSF biomarker profiles onto NIA-AA guidelines for Alzheimer's disease.
-
Optical coherence tomography indicates disease activity prior to clinical onset of central nervous system demyelination.
-
Biomarkers of treatment response in multiple sclerosis
-
JC polyomavirus infection is strongly controlled by human leucocyte antigen class II variants
-
Atrophy and structural variability of the upper cervical cord in early multiple sclerosis.
-
Review of the pharmacoeconomics of early treatment of multiple sclerosis using interferon beta
-
Fully Bayesian inference for structural MRI: application to segmentation and statistical analysis of T2-hypointensities
-
Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis
-
Anti-JC virus antibody prevalence in a multinational multiple sclerosis cohort
-
Reply to Dr Pandey
-
Natalizumab treatment decreases serum IgM and IgG levels in multiple sclerosis patients
-
L-selectin is a possible biomarker for individual PML risk in natalizumab-treated MS patients.
-
White-matter lesions drive deep gray-matter atrophy in early multiple sclerosis: support from structural MRI.
-
Potassium channel KIR4.1 as an immune target in multiple sclerosis
-
18F-FDG PET detects inflammatory infiltrates in spinal cord experimental autoimmune encephalomyelitis lesions.
-
Genetic variants in the immunoglobulin heavy chain locus are associated with the IgG index in multiple sclerosis
-
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
Human - wd:Q86996405